BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24525443)

  • 1. Multimodal management of malignant pleural mesothelioma: where are we today?
    Van Schil PE; Opitz I; Weder W; De Laet C; Domen A; Lauwers P; Hendriks JM; Van Meerbeeck JP
    Eur Respir J; 2014 Sep; 44(3):754-64. PubMed ID: 24525443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
    Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
    Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current surgical strategies for malignant pleural mesothelioma.
    Takuwa T; Hasegawa S
    Surg Today; 2016 Aug; 46(8):887-94. PubMed ID: 26590581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleural mesothelioma: is the surgeon still there?
    Opitz I; Weder W
    Ann Oncol; 2018 Aug; 29(8):1710-1717. PubMed ID: 29905765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interim results of pleurectomy/decortication and intraoperative intrapleural hyperthermic cisplatin perfusion for patients with malignant pleural mesothelioma intolerable to extrapleural pneumonectomy.
    Ishibashi H; Kobayashi M; Takasaki C; Okubo K
    Gen Thorac Cardiovasc Surg; 2015 Jul; 63(7):395-400. PubMed ID: 25750109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved Outcomes with Modern Lung-Sparing Trimodality Therapy in Patients with Malignant Pleural Mesothelioma.
    Shaikh F; Zauderer MG; von Reibnitz D; Wu AJ; Yorke ED; Foster A; Shi W; Zhang Z; Adusumilli PS; Rosenzweig KE; Krug LM; Rusch VW; Rimner A
    J Thorac Oncol; 2017 Jun; 12(6):993-1000. PubMed ID: 28341225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should we continue to offer extrapleural pneumonectomy to selected mesothelioma patients? A single center experience comparing surgical and non-surgical management.
    Baud M; Bobbio A; Lococo F; Regnard JF; Alifano M
    Jpn J Clin Oncol; 2014 Nov; 44(11):1127-9. PubMed ID: 25187665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined modality treatment for malignant pleural mesothelioma: a single-centre long-term survival analysis using extrapleural pneumonectomy.
    Frick AE; Nackaerts K; Moons J; Lievens Y; Verbeken E; Lambrecht M; Coolen J; Dooms C; Vansteenkiste J; De Leyn P; Nafteux P
    Eur J Cardiothorac Surg; 2019 May; 55(5):934-941. PubMed ID: 30535191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review of pleurectomy in the treatment of malignant pleural mesothelioma.
    Cao C; Tian DH; Pataky KA; Yan TD
    Lung Cancer; 2013 Sep; 81(3):319-327. PubMed ID: 23769317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleurectomy/decortication, hyperthermic pleural lavage with povidone-iodine, prophylactic radiotherapy, and systemic chemotherapy in patients with malignant pleural mesothelioma: a 10-year experience.
    Lang-Lazdunski L; Bille A; Papa S; Marshall S; Lal R; Galeone C; Landau D; Steele J; Spicer J
    J Thorac Cardiovasc Surg; 2015 Feb; 149(2):558-65; discussion 565-6. PubMed ID: 25726878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taken Together: Effective Multimodal Approaches for Malignant Pleural Mesothelioma.
    Song KJ; Flores RM; Wolf AS
    Thorac Surg Clin; 2020 Nov; 30(4):481-487. PubMed ID: 33012435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Return to intended oncologic treatment after surgery for malignant pleural mesothelioma.
    Nelson DB; Rice DC; Mitchell KG; Tsao AS; Gomez DR; Sepesi B; Mehran RJ
    J Thorac Cardiovasc Surg; 2019 Sep; 158(3):924-929. PubMed ID: 31430846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extrapleural pneumonectomy for malignant pleural mesothelioma: is this an operation that should now be consigned to history?
    Treasure T
    Future Oncol; 2015; 11(24 Suppl):7-10. PubMed ID: 26638915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How does the timing of chemotherapy affect outcome following radical surgery for malignant pleural mesothelioma?
    Sharkey AJ; O'Byrne KJ; Nakas A; Tenconi S; Fennell DA; Waller DA
    Lung Cancer; 2016 Oct; 100():5-13. PubMed ID: 27597274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Risk and Survival Associated With Less Invasive Surgery for Malignant Pleural Mesothelioma.
    Hasegawa S; Kondo N; Matsumoto S; Takuwa T; Hashimoto M; Kuroda A; Nakamichi T; Kamikonya N; Tsujimura T; Nakano T
    Semin Thorac Cardiovasc Surg; 2019; 31(2):301-309. PubMed ID: 30639549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-institution experience of intensity-modulated radiotherapy for malignant pleural mesothelioma at University of Catania.
    Spatola C; Militello C; Tocco A; Salamone V; Luigi R; Migliore M; Marletta D; Cannizzaro A; Bevilacqua R; Milone P; Pergolizzi S; Privitera G
    Future Oncol; 2018 Mar; 14(6s):17-21. PubMed ID: 29400553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleurectomy/decortication plus chemotherapy: outcomes of 40 cases of malignant pleural mesothelioma.
    Colaut F; Toniolo L; Vicario G; Scapinello A; Visentin C; Manente P; Sartori CA
    Chir Ital; 2004; 56(6):781-6. PubMed ID: 15771030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The state of the art in the technical performance of lung-sparing operations for malignant pleural mesothelioma.
    Friedberg JS
    Semin Thorac Cardiovasc Surg; 2013; 25(2):125-43. PubMed ID: 24216529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.